Center of Psychotherapy, Psychosomatics and Psychedelic Medicine Expio

Opening Hours : Mon-Fri 10.00 - 19.00.

Tel. +380 7373 080 88

Archive for August 2024

2024-08-24_125823

Synergy of ketamine and psychotherapy: a new approach to the treatment of psychiatric disorders

In today's world, more and more people are dealing with mental disorders such as depression, anxiety and post-traumatic stress disorder (PTSD). Traditional treatments, which include drug therapy and psychotherapy, are often time-consuming and not always effective for all patients. However, new research reviewed in the journal's scientific review Frontiers in Psychology, open the prospect of using ketamine in combination with psychotherapy, which can significantly increase the effectiveness of treatment.

What is ketamine and how does it work?

Ketamine is a drug that was originally developed as an anesthetic. However, in the 21st century, scientists have drawn attention to its potential in the treatment of depression and other mental disorders. Ketamine acts on the glutamate receptors in the brain, which helps to change the neural connections and helps to quickly relieve the symptoms of depression. Unlike traditional anti-depressants, which can take weeks to start working, ketamine shows its effects within hours of administration.

Read More
borderline-personality-disorder

Ketamine therapy for the treatment of borderline personality disorder

A recent study published in the journal Nature, studied the potential of using ketamine to treat patients with borderline personality disorder (BPD). In a pilot randomized controlled trial, scientists investigated the effect of a single dose of ketamine on the emotional state of patients.

Borderline personality disorder is a complex mental disorder characterized by significant emotional instability, impulsive behavior, a tendency to self-harm, and difficulties in relationships. Traditional treatments for BPD include therapy, antidepressants, and mood stabilizers, but these approaches often take a long time to achieve significant effects.

Read More
lecture

Strategic seminar in Warsaw "Psychedelics in the treatment of war injuries"

In mid-June of this year, the director of the Expio center Wladyslaw Matrenytskyi took part in an international seminar in Warsaw, which was organized by the European Alliance for Psychedelic Access and Research (PAREA) in cooperation with the Open Society Foundation, the International Renaissance Foundation, the Helsinki Human Rights Foundation and the Ukrainian Association psychedelic research.

The main goal of the workshop was to develop a common situational understanding and program
advocacy, as well as providing tools and expertise to support Ukraine in expanding access
to psychedelic therapy for people with post-traumatic stress disorder associated with
by war

Read More